3/19
09:08 am
cvm
CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology [Yahoo! Finance]
Low
Report
CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology [Yahoo! Finance]
3/19
09:00 am
cvm
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
Low
Report
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
3/15
02:15 am
cvm
CEL-SCI Co. (NYSE: CVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
CEL-SCI Co. (NYSE: CVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/7
11:05 pm
cvm
CEL-SCI Co. (NYSE: CVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
CEL-SCI Co. (NYSE: CVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/6
08:58 am
cvm
CEL-SCI Corporation Issues Letter to Shareholders [Yahoo! Finance]
Medium
Report
CEL-SCI Corporation Issues Letter to Shareholders [Yahoo! Finance]
3/6
08:45 am
cvm
CEL-SCI Corporation Issues Letter to Shareholders
Medium
Report
CEL-SCI Corporation Issues Letter to Shareholders
2/15
08:19 am
cvm
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results [Yahoo! Finance]
Low
Report
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results [Yahoo! Finance]
2/15
08:00 am
cvm
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
Low
Report
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
2/13
12:00 pm
cvm
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
Low
Report
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
2/12
01:42 am
cvm
Cel-Sci: Fabulous Story Stock Works To Pass Muster With FDA [Seeking Alpha]
Medium
Report
Cel-Sci: Fabulous Story Stock Works To Pass Muster With FDA [Seeking Alpha]
2/9
08:55 am
cvm
CEL-SCI Slides After Follow-on Offering Prices Below Market Price [MarketWatch]
Medium
Report
CEL-SCI Slides After Follow-on Offering Prices Below Market Price [MarketWatch]
2/9
08:47 am
cvm
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock [Yahoo! Finance]
Medium
Report
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock [Yahoo! Finance]
2/9
08:30 am
cvm
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
Medium
Report
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
2/6
09:26 am
cvm
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug [Yahoo! Finance]
Medium
Report
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug [Yahoo! Finance]
2/6
09:00 am
cvm
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
Medium
Report
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
1/31
09:13 am
cvm
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine® [Yahoo! Finance]
Low
Report
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine® [Yahoo! Finance]
1/31
09:00 am
cvm
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®
Low
Report
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®